BioNTech SE
BNTX
•Stock Analysis$105.14
+0.00 (+0.00%)• Live
BioNTech SE Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for BioNTech SE
Key Financial Metrics
for BioNTech SE
P/E Ratio
-28.51
Revenue Growth
-27.96%
EPS Growth
-171.58%
Market Cap
$22.03B
Dividend Yield
0.00%
Debt/Equity
0.02
ROIC
-5.30%
FCF Yield
-5.23%
View additional metrics
Valuation
P/B Ratio1.16
EV/Sales4.45
Financial Health
Current Ratio10.18
Return on Assets-4.00%
Analyst Recommendations
for BioNTech SE
24 analysts
Consensus: Buy
About
for BioNTech SE
Company Details
for BioNTech SE
Sector
Healthcare
Industry
Biotechnology
CEO
Ugur Sahin
Employees
6,772
Market Cap
25.28B
Exchange
NASDAQ Global Select
IPO Date
October 10, 2019
Website
www.biontech.deCIK
0001776985
ISIN
US09075V1026
CUSIP
09075V102
Country
DE
Balance Sheet
for BioNTech SE
Cash Flow Statement
for BioNTech SE
Income Statement
for BioNTech SE
News
No news available at the moment.